We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+18.5%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$15.5B
AUM Growth
+$2.94B
Cap. Flow
+$1.45B
Cap. Flow %
9.35%
Top 10 Hldgs %
30.63%
Holding
2,230
New
735
Increased
384
Reduced
378
Closed
720

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$614M
2
AAPL icon
Apple
AAPL
+$443M
3
BLD
TopBuild
BLD
+$391M
4
SPCX
SpaceX
SPCX
+$329M
5
PEN icon
Penumbra
PEN
+$203M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.96B
2
NVDA icon
NVIDIA
NVDA
+$425M
3
SNDK
Sandisk
SNDK
+$88M
4
SO icon
Southern Company
SO
+$80.6M
5
PPL
PPL Corp
PPL
+$74.1M

Sector Composition

Rank Sector Weight
1 Technology 16.4%
2 Industrials 13.64%
3 Consumer Discretionary 9.5%
4 Healthcare 7.9%
5 Financials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BXC icon
1376
BlueLinx
BXC
$665M
$275K ﹤0.01%
+4,442
New +$240K
TAC icon
1377
TransAlta
TAC
$3.86B
$275K ﹤0.01%
+19,858
New +$262K
QUAD icon
1378
Quad
QUAD
$532M
$275K ﹤0.01%
+32,567
New +$245K
PWP icon
1379
Perella Weinberg Partners
PWP
$1.23B
$272K ﹤0.01%
+17,063
New +$312K
IRDM icon
1380
Iridium Communications
IRDM
$5.19B
$272K ﹤0.01%
4,961
-57,489
-92% -$2.46M
TXG icon
1381
10x Genomics
TXG
$8.48B
$271K ﹤0.01%
+7,081
New +$186K
BMO icon
1382
Bank of Montreal
BMO
$122B
$269K ﹤0.01%
+1,520
New +$239K
CTEV
1383
Claritev Corp
CTEV
$632M
$267K ﹤0.01%
+7,824
New +$192K
WEAV icon
1384
Weave Communications
WEAV
$583M
$266K ﹤0.01%
+44,465
New +$242K
BVS icon
1385
Bioventus
BVS
$982M
$266K ﹤0.01%
+28,154
New +$269K
PBLS
1386
Parabilis Medicines Inc
PBLS
$4.86B
$265K ﹤0.01%
+9,691
New +$268K
GCTS
1387
GCT Semiconductor Holding
GCTS
$188M
$263K ﹤0.01%
+88,539
New +$188K
XTL icon
1388
State Street SPDR S&P Telecom ETF
XTL
$521M
$262K ﹤0.01%
+1,150
New +$256K
RYAM icon
1389
Rayonier Advanced Materials
RYAM
$586M
$260K ﹤0.01%
+33,084
New +$300K
KPTI icon
1390
Karyopharm Therapeutics
KPTI
$44.5M
$260K ﹤0.01%
+26,582
New +$231K
AMR icon
1391
Alpha Metallurgical Resources
AMR
$2.66B
$258K ﹤0.01%
1,564
-2,112
-57% -$403K
LITE icon
1392
CALL
Lumentum
LITE
$77.7B
$257K ﹤0.01%
+300
New +$268K
SPFI icon
1393
South Plains Financial
SPFI
$833M
$257K ﹤0.01%
+5,958
New +$249K
FR icon
1394
First Industrial Realty Trust
FR
$8.34B
$255K ﹤0.01%
+4,165
New +$258K
USAR
1395
USA Rare Earth Inc
USAR
$4.71B
$254K ﹤0.01%
11,749
-80,719
-87% -$1.84M
CDZI icon
1396
Cadiz
CDZI
$310M
$253K ﹤0.01%
60,539
-80,033
-57% -$357K
RNGR icon
1397
Ranger Energy Services
RNGR
$401M
$252K ﹤0.01%
+15,746
New +$258K
SKYH icon
1398
Sky Harbour Group
SKYH
$402M
$252K ﹤0.01%
+25,559
New +$250K
ASYS icon
1399
Amtech Systems
ASYS
$256M
$244K ﹤0.01%
+10,557
New +$200K
CAL icon
1400
Caleres
CAL
$457M
$240K ﹤0.01%
19,419
-54,572
-74% -$708K

Similar funds

Michael Gelband's Q2 2026 Portfolio in Review

As of Q2 2026, Michael Gelband held 2,230 positions worth $15.5B, up 23% from $12.6B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Michael Gelband deployed $1.45B of net new capital in Q2 2026, opening 735 new positions and adding to 384 existing holdings. Its largest new stake was SpaceX: 1,938,935 shares worth $331M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Tesla, an estimated $1.96B trimmed.

  • Michael Gelband's largest Q2 2026 buy was SpaceX: 1,938,935 shares worth $331M.
  • Michael Gelband added most to Amazon in Q2 2026, an estimated $614M increase.
  • Michael Gelband's biggest Q2 2026 reduction was Tesla, cutting an estimated $1.96B.
  • Michael Gelband fully exited Southern Company in Q2 2026, selling an estimated $80.6M.
  • Michael Gelband's ten largest holdings make up 31% of its $15.5B portfolio in Q2 2026.
  • Michael Gelband opened 735 new positions and closed 720 in Q2 2026.
  • Michael Gelband's portfolio value rose 23% quarter-over-quarter to $15.5B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.